Related Experiment Video

Updated: Dec 8, 2025

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.6K

Inactivation of ApoC3 by CRISPR/Cas9 Protects Against Atherosclerosis in Hamsters

Mengmeng Guo1, Yitong Xu2, Zhao Dong1

  • 1Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing, China (M.G., Z.D., Z.Z., N.C., W.H., Y.W., G.L., X.X.).

Circulation Research
|September 21, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
apolipoproteinatherosclerosiscardiovascular diseaselipoprotein lipasemice

More Related Videos

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

20.8K
Production of Genetically Engineered Golden Syrian Hamsters by Pronuclear Injection of the CRISPR/Cas9 Complex06:12

Production of Genetically Engineered Golden Syrian Hamsters by Pronuclear Injection of the CRISPR/Cas9 Complex

Published on: January 9, 2018

13.6K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
225